Dose-Escalation and Dose-Expansion Study to Evaluate the Safety and Tolerability of Anti-CD7 Allogeneic CAR T-Cells (WU-CART-007) in Patients With CD7+ Hematologic Malignancies
Washington University School of Medicine
Washington University School of Medicine
Wake Forest University Health Sciences
Stanford University
Stanford University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
Jonsson Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Swiss Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Massachusetts General Hospital
University of Louisville
Alliance for Clinical Trials in Oncology
Progen Pharmaceuticals
Morphotek
Case Comprehensive Cancer Center
National Cancer Institute (NCI)
City of Hope Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Indiana University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Boston Medical Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Fox Chase Cancer Center